83 related articles for article (PubMed ID: 12579886)
1. [Protective effect of ONO-1078, a leukotriene antagonist, on focal cerebral ischemia in mice].
Zeng LH; Zhang WP; Wang RD; Wang PL; Wei EQ
Yao Xue Xue Bao; 2001 Feb; 36(2):148-50. PubMed ID: 12579886
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia in rats.
Zhang WP; Wei EQ; Mei RH; Zhu CY; Zhao MH
Acta Pharmacol Sin; 2002 Oct; 23(10):871-7. PubMed ID: 12370090
[TBL] [Abstract][Full Text] [Related]
3. [An improved quantitative method for evaluating neurological deficits in mice with focal cerebral ischemia].
Wei EQ; Zhu CY; Xu QQ; Yu YP; Zhu YF; Zheng MZ
Sheng Li Xue Bao; 2003 Dec; 55(6):742-7. PubMed ID: 14695495
[TBL] [Abstract][Full Text] [Related]
4. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice.
Yu GL; Wei EQ; Zhang SH; Xu HM; Chu LS; Zhang WP; Zhang Q; Chen Z; Mei RH; Zhao MH
Pharmacology; 2005 Jan; 73(1):31-40. PubMed ID: 15452361
[TBL] [Abstract][Full Text] [Related]
5. [Protective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia induced by endothelin-1 in rats].
Zhang SH; Wei EQ; Zhu CY; Chen Z; Zhang SF
Yao Xue Xue Bao; 2004 Jan; 39(1):1-4. PubMed ID: 15127571
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on transient global cerebral ischemia in rats.
Zhang LH; Wei EQ
Acta Pharmacol Sin; 2003 Dec; 24(12):1241-7. PubMed ID: 14653951
[TBL] [Abstract][Full Text] [Related]
7. Pranlukast reduces neutrophil but not macrophage/microglial accumulation in brain after focal cerebral ischemia in mice.
Chu LS; Wei EQ; Yu GL; Fang SH; Zhou Y; Wang ML; Zhang WP
Acta Pharmacol Sin; 2006 Mar; 27(3):282-8. PubMed ID: 16490162
[TBL] [Abstract][Full Text] [Related]
8. HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats.
Shi QJ; Wang H; Liu ZX; Fang SH; Song XM; Lu YB; Zhang WP; Sa XY; Ying HZ; Wei EQ
Neuroscience; 2015 Apr; 291():53-69. PubMed ID: 25681271
[TBL] [Abstract][Full Text] [Related]
9. Pranlukast, a cysteinyl leukotriene receptor-1 antagonist, protects against chronic ischemic brain injury and inhibits the glial scar formation in mice.
Yu GL; Wei EQ; Wang ML; Zhang WP; Zhang SH; Weng JQ; Chu LS; Fang SH; Zhou Y; Chen Z; Zhang Q; Zhang LH
Brain Res; 2005 Aug; 1053(1-2):116-25. PubMed ID: 16051204
[TBL] [Abstract][Full Text] [Related]
10. [Effects of edaravone, minocycline and ONO-1078 on oxygen/glucose deprivation-induced electrophysiological alteration in rat hippocampal slices].
Li W; Wei EQ; Wang ML; Liu LY
Yao Xue Xue Bao; 2004 Feb; 39(2):81-4. PubMed ID: 15127610
[TBL] [Abstract][Full Text] [Related]
11. [Protective effect of hydroxysafflor yellow A on experimental cerebral ischemia in rats].
Zhu HB; Wang ZH; Tian JW; Fu FH; Liu K; Li CL
Yao Xue Xue Bao; 2005 Dec; 40(12):1144-6. PubMed ID: 16496682
[TBL] [Abstract][Full Text] [Related]
12. ONO-1078 reduces NMDA-induced brain injury and vascular cell adhesion molecule-1 expression in rats.
Zhang LH; Wei EQ
Acta Pharmacol Sin; 2005 Apr; 26(4):435-40. PubMed ID: 15780192
[TBL] [Abstract][Full Text] [Related]
13. Intracerebroventricular injection of HAMI 3379, a selective cysteinyl leukotriene receptor 2 antagonist, protects against acute brain injury after focal cerebral ischemia in rats.
Shi QJ; Xiao L; Zhao B; Zhang XY; Wang XR; Xu DM; Yu SY; Fang SH; Lu YB; Zhang WP; Sa XY; Wei EQ
Brain Res; 2012 Nov; 1484():57-67. PubMed ID: 23000196
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of cysteinyl leukotriene receptor-1 in the brain mediates neuronal damage and astrogliosis after focal cerebral ischemia in rats.
Fang SH; Wei EQ; Zhou Y; Wang ML; Zhang WP; Yu GL; Chu LS; Chen Z
Neuroscience; 2006 Jul; 140(3):969-79. PubMed ID: 16650938
[TBL] [Abstract][Full Text] [Related]
15. The therapeutic value of nimodipine in experimental focal cerebral ischemia. Neurological outcome and histopathological findings.
Germano IM; Bartkowski HM; Cassel ME; Pitts LH
J Neurosurg; 1987 Jul; 67(1):81-7. PubMed ID: 3598674
[TBL] [Abstract][Full Text] [Related]
16. High-dose methylprednisolone treatment in experimental focal cerebral ischemia.
Slivka AP; Murphy EJ
Exp Neurol; 2001 Jan; 167(1):166-72. PubMed ID: 11161604
[TBL] [Abstract][Full Text] [Related]
17. EDT, a tetrahydroacridine derivative inhibits cerebral ischemia and protects rat cortical neurons against glutamate-induced cytotoxicity.
Sheng R; Liu GQ
Acta Pharmacol Sin; 2003 May; 24(5):390-3. PubMed ID: 12740171
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective activity of tamoxifen in permanent focal ischemia.
Kimelberg HK; Jin Y; Charniga C; Feustel PJ
J Neurosurg; 2003 Jul; 99(1):138-42. PubMed ID: 12854756
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors.
Dong W; Li N; Gao D; Zhen H; Zhang X; Li F
J Vasc Surg; 2008 Sep; 48(3):709-14. PubMed ID: 18572362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
